ArticleAnnals of medicine and surgery (2012)2025
Upfront hepaticojejunostomy in portal biliopathy: is a decompressive shunt always necessary?
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & aims: Hepaticojejunostomy (HJ) for portal biliopathy (PB) in extrahepatic portal venous obstruction is considered to be difficult and associated with major intraoperative bleeding due to the raised pressure in periportal collaterals. Upfront HJ is deemed unsafe and advocated to be a second stage procedure after a prior decompressive splenorenal shunt to reduce the pressure in the periportal veins. However, in some cases with dominant biliary presentation or if the shunt is not possible/ineffective, upfront HJ is an alternate. The study is done to assess the feasibility, complications and effectiveness of an upfront HJ in patients with PB. Methods: The outcome of HJ was analyzed in two groups of patients with PB. Group A had 11 (HJ after a prior decompressive splenorenal shunt) while group B had 9 patients (upfront HJ). The end points were the feasibility of the procedure, postoperative complications and long-term stricture rate. Results: The upfront HJ was feasible in 8/9 patients in group B with lesser duration of surgery (325.4 ± 167.3 vs 396.3 ± 147.8 min), blood loss (750 ± 775.4 vs 803.6 ± 787.1 mL) and blood transfusion (4.1 ± 1.9 vs 4.3 ± 3.13 units). It had lesser grade III and above complications. Biliary obstruction was relieved in 8/9 patients in group B with one intrahepatic biliary stricture. Conclusions: In patients of PB with dominant biliary presentation and non-shuntable vein, despite limitations, upfront HJ without a prior shunt, albeit a difficult procedure, is a feasible and an effective option with acceptable complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.